Search Within

RENAL CELL CARCINOMA

Structure-Based Virtual Screening for the Identification of High Affinity Compounds as Potent VEGFR2 Inhibitors for the Treatment of Renal Cell Carcinoma

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 25
Page: 2174-2185
Authors: Khushboo Sharma, Khushboo Patidar, Meer Asif Ali, Pravin Patil, Himshikha Goud, Tajamul Hussain, Anuraj Nayarisseri* and Sanjeev Kumar Singh*

Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Platelet-derived Growth Factor Receptor (PDGFR) Kinase Inhibitors

Journal: Current Drug Metabolism
Volume: 19, Issue: 14
Page: 1168-1181
Authors: Yi Qian, Lei Yu, Xue-Hui Zhang, Zi-Qing-Yun Yuan, Ping Zhao, Lu-Ning Sun* and Yong-Qing Wang*

Selecting Patients with Small Renal Masses for Active Surveillance

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 7
Page: 931-939
Authors: Michael H. Johnson, Mohamad E. Allaf and Phillip M. Pierorazio*

Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 27
Page: 3256-3271
Authors: Shikun Yang, Aimei Li, JianWen Wang, Jun Liu, Yachun Han, Wei Zhang, Yan Chun Li and Hao Zhang*

Therapeutic Drug Monitoring of Targeted Therapy in Metastatic Renal Cell Carcinoma

Journal: Protein & Peptide Letters
Volume: 25, Issue: 6
Page: 528-533
Authors: Dehua Liao, Dangang Shangguan, Dunwu Yao, Qing Zhu, Lizhi Cao, Minghui Long, Yi Wu, Daxiong Xiang* and Nong Yang*

Immunomodulatory Therapies for Renal Cell Carcinoma

Journal: Protein & Peptide Letters
Volume: 25, Issue: 6
Page: 534-547
Authors: Min Liu, Huizi Wu, Dangang Shangguan, Yueping Jiang, Xiangping Li, Shao Liu, Boting Zhou, Tao Yin and Zhicheng Gong*

Current and Emerging Treatments for Metastatic Renal Cell Carcinoma

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 5
Page: 468-479
Authors: Carla Cavaliere, Carmine D`Aniello, Chiara Della Pepa, Salvatore Pisconti, Massimiliano Berretta and Gaetano Facchini*

Vascular Endothelial Growth Factor Inhibitor Therapy and Cardiovascular and Renal Damage in Renal Cell Carcinoma

Journal: Current Vascular Pharmacology
Volume: 16, Issue: 2
Page: 190-196
Authors: Silvia Lai*, Alessio Molfino, Patrizia Seminara, Flavia Longo, Georgie Innico, Bettina Coppola, Daniela Mastroluca, Alessandro Galani , Mira Dimko, Paola Aceto and Carlo Lai

May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing Trials

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 12
Page: 1633-1643
Authors: Carlo Messina, Elisa Zanardi* and Francesco Boccardo

Combined Treatment with CCI779 and SB203580 Induces Cellular Senescence in Renal Cell Carcinoma Cell Line via p53 Pathway

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 11
Page: 1545-1554
Authors: Ashutosh Chauhan*, Rani Ojha, Deepak K. Semwal*, Satyendra P. Mishra and Ruchi B. Semwal

Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives

Journal: Current Drug Metabolism
Volume: 18, Issue: 8
Page: 700-711
Authors: Steven A. Mann, Antonio Lopez-Beltran, Francesco Massari, Roberto Pili, Michelangelo Fiorentino, Michael O. Koch, Hristos Z. Kaimakliotis, Lisha Wang, Marina Scarpelli, Chiara Ciccarese, Holger Moch, Rodolfo Montironi and Liang Cheng*

Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review

Journal: Current Drug Targets
Volume: 18, Issue: 10
Page: 1204-1213
Authors: Simone A.M. Badal*, William D. Aiken and Sheray N. Chin

Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report

Journal: Current Drug Targets
Volume: 17, Issue: 15
Page: 1755-1760
Authors: Melissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, Mariarosa Maiorana and Sebastiano Buti

Current Immunotherapies for Renal Cell Carcinoma

Journal: Current Molecular Pharmacology
Volume: 9, Issue: 3
Page: 252-263
Authors: Mhd. Yaser Al-Marrawi and Sheldon L. Holder

A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer

Journal: Current Drug Delivery
Volume: 13, Issue: 2
Page: 186-201
Authors: K. Venkata Sairam, B. M. Gurupadayya, R. S. Chandan, Dattatri K. Nagesha and B. Vishwanathan

Emerging Immunotargets in Metastatic Renal Cell Carcinoma

Journal: Current Drug Targets
Volume: 17, Issue: 7
Page: 771-776
Authors: John Kucharczyk, Marc R. Matrana, Matteo Santoni, Francesco Massari, Marina Scarpelli, Liang Cheng, Antonio Lopez-Beltran, Stefano Cascinu, Rodolfo Montironi and Moch Holger

An Overview of Emerging Immunotargets of Genitourinary Tumors

Journal: Current Drug Targets
Volume: 17, Issue: 7
Page: 750-756
Authors: Rodolfo Montironi, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Marc R. Matrana, Holger Moch and Marina Scarpelli

Metabolic Alterations in Renal and Prostate Cancer

Journal: Current Drug Metabolism
Volume: 17, Issue: 2
Page: 150-155
Authors: Chiara Ciccarese, Matteo Santoni, Francesco Massari, Alessandra Modena, Francesco Piva, Alessandro Conti, Roberta Mazzucchelli, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Giampaolo Tortora and Rodolfo Montironi

MicroRNAs in Renal Cell Carcinoma

Journal: MicroRNA
Volume: 4, Issue: 1
Page: 26-35
Authors: Donald F. Sellitti and Sonia Q. Doi

Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical Application

Journal: Current Vascular Pharmacology
Volume: 13, Issue: 3
Page: 381-391
Authors: Ole H. Nielsen, Daniela Grimm, Markus Wehland, Johann Bauer and Nils E. Magnusson

Oncotargets in Different Renal Cancer Subtypes

Journal: Current Drug Targets
Volume: 16, Issue: 2
Page: 125-135
Authors: Holger Moch, Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng and Axel Mischo

Serotonin and Cancer: What Is the Link?

Journal: Current Molecular Medicine
Volume: 15, Issue: 1
Page: 62-77
Authors: D. Sarrouilhe, J. Clarhaut, N. Defamie and M. Mesnil

Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 2
Page: 88-96
Authors: Fadi El Karak, Hampig Raphael Kourie, Ralph Chebib, Samer Tabchi, Alain Daher, Joseph Kattan and Marwan Ghosn

Biomarkers for VEGF-Targeted Therapy in Renal Cell Carcinoma: Critical Review of Level of Evidence and Up to Date

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 4, Issue: 2
Page: 119-127
Authors: Minardi Daniele, Quaresima Luigi, Conti Alessandro, Matteo Santoni, Milanese Giulio and Muzzonigro Giovanni

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15, Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal

Renal Cell Carcinoma Cancer Stem Cells as Therapeutic Targets

Journal: Current Signal Transduction Therapy
Volume: 8, Issue: 3
Page: 203-209
Authors: Anna M. Czarnecka and Cezary Szczylik

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma

Journal: Current Signal Transduction Therapy
Volume: 8, Issue: 3
Page: 210-218
Authors: Anna Kornakiewicz, Wojciech Solarek, Zofia F. Bielecka, Fei Lian, Cezary Szczylik and Anna M. Czarnecka

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)

Journal: Current Signal Transduction Therapy
Volume: 8, Issue: 3
Page: 219-228
Authors: Zofia F. Bielecka, Anna M. Czarnecka, Wojciech Solarek, Anna Kornakiewicz and Cezary Szczylik

Immunotherapy Resistance Mechanisms in Renal Cell Cancer

Journal: Current Signal Transduction Therapy
Volume: 8, Issue: 3
Page: 247-255
Authors: Katarzyna Kaminska, Gabriel Wcislo, Anna M. Czarnecka, Salem Chouaib and Cezary Szczylik

Renal Cell Carcinoma in a Patient with Rheumatoid Arthritis Treated with Adalimumab

Journal: Current Drug Safety
Volume: 9, Issue: 1
Page: 69-72
Authors: Senol Kobak, Ahmet Karaarslan and Yunus Aktakka

Orai1 and Transient Receptor Potential Channels as Novel Molecular Targets to Impair Tumor Neovascularization in Renal Cell Carcinoma and other Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14, Issue: 2
Page: 296-312
Authors: Francesco Moccia, Silvia Dragoni, Valentina Poletto, Vittorio Rosti, Franco Tanzi, Carlo Ganini and Camillo Porta

Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?

Journal: Current Cancer Drug Targets
Volume: 13, Issue: 3
Page: 313-325
Authors: Matteo Santoni, Mimma Rizzo, Luciano Burattini, Rossana Berardi, Giacomo Carteni and Stefano Cascinu

Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma

Journal: Current Cancer Drug Targets
Volume: 13, Issue: 2
Page: 126-142
Authors: Daniel C. Cho and James W. Mier

Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma

Journal: Current Cancer Drug Targets
Volume: 13, Issue: 3
Page: 300-312
Authors: Jordi Muntane, Angel J. De la Rosa, Fernando Docobo, Rocio Garcia-Carbonero and Francisco J. Padillo

State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 28
Page: 4875-4884
Authors: G. Zauli, R. Voltan, V. Tisato and P. Secchiero

A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma

Journal: Current Cancer Drug Targets
Volume: 12, Issue: 7
Page: 857-872
Authors: Z. Mihaly, Z. Sztupinszki, P. Surowiak and B. Gyorffy

Non-aspirin Non-steroidal Anti-inflammatory Drugs for the Primary Chemoprevention of Non-gastrointestinal Cancer: Summary of Evidence

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 26
Page: 4047-4070
Authors: Marcus Tolentino Silva, Tais Freire Galvao, Ivan Ricardo Zimmerman, Mauricio Gomes Pereira and Luciane Cruz Lopes

Present and Future of Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: Analysis of Hematologic Toxicity

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 7, Issue: 2
Page: 104-110
Authors: Matteo Santoni, Mimma Rizzo, Luciano Burattini, Valerio Farfariello, Rossana Berardi, Giorgio Santoni, Giacomo Carteni and Stefano Cascinu

Tumor Angiogenesis: A Target for Renal Cell Carcinoma Therapy. Current Perspectives and Novel Strategies

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 2, Issue: 2
Page: 99-106
Authors: Matteo Santoni, Daniele Minardi, Luciano Burattini, Rami Raquban, Stefano Cascinu and Giovanni Muzzonigro

Targeting mTOR Pathways in Human Malignancies

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 19
Page: 2766-2777
Authors: Angelica Fasolo and Cristiana Sessa

Costimulation, Coinhibition and Cancer

Journal: Current Cancer Drug Targets
Volume: 7, Issue: 1
Page: 15-30
Authors: Brant A. Inman, Xavier Frigola, Haidong Dong and Eugene D. Kwon

Chromosome 3 Translocations and Familial Renal Cell Cancer

Journal: Current Molecular Medicine
Volume: 4, Issue: 8
Page: 849-854
Authors: Anita C.M. Bonne, Danielle Bodmer, Eric F.P.M. Schoenmakers, Conny M. van Ravenswaaij, Nicoline Hoogerbrugge and Ad Geurts van Kessel

Targeting Angiogenesis in Renal Cell Carcinoma

Journal: Current Cancer Drug Targets
Volume: 8, Issue: 5
Page: 349-358
Authors: Georgios Lainakis and Aristotle Bamias

Interferon Therapy for Malignant Solid Tumors

Journal: Current Drug Therapy
Volume: 5, Issue: 2
Page: 132-138
Authors: Katherine E. Warren and Howard A. Young

Immunotherapy of Kidney Cancer

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 151-163
Authors: Petros D. Grivas and Bruce G. Redman

Evolving Molecular Mechanism-Based Strategies for Control of Hepatocellular Carcinoma

Journal: Current Medicinal Chemistry
Volume: 18, Issue: 28
Page: 4375-4388
Authors: K. Sato and M. Mori

Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4, Issue: 2
Page: 146-156
Authors: Emmanuel Seront and Jean-Pascal Machiels

SDH Genes: From Glomic Tumours to Pheochromocytomas

Journal: Current Hypertension Reviews
Volume: 1, Issue: 3
Page: 267-273
Authors: Alexander Persu and Miikka Vikkula

Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)

Journal: Current Molecular Medicine
Volume: 4, Issue: 8
Page: 869-875
Authors: Maija Kiuru and Virpi Launonen

The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors

Journal: Current Cancer Therapy Reviews
Volume: 4, Issue: 3
Page: 227-234
Authors: Arun Rajan and Ajeet Gajra

The mTOR Pathway: A New Target in Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 10, Issue: 5
Page: 484-495
Authors: L. Ciuffreda, C. Di Sanza, U.C. Incani and M. Milella

VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 164-168
Authors: Toni K. Choueiri

TEM8 Targeted Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11, Issue: 10
Page: 983-992
Authors: Arthur E. Frankel, Carol Carter, Shu-Ru Kuo, Jung-Hee Woo, Jeremy Mauldin and Jen-Sing Liu

Anti-Angiogenic Therapy in Renal Cell Carcinoma

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5, Issue: 1
Page: 77-83
Authors: Shree G. Sharma, Sudip Nanda and Santo Longo

Current Strategy in the Treatment of Metastatic Renal Cell Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 1, Issue: 2
Page: 127-137
Authors: Alain Ravaud, Marie-Sarah Dilhuydy, Aimery Huchet, Stephane Pedeboscq and Jean-Philippe Maire

Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 12
Page: 1013-1022
Authors: B. C. Yegen

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 8, Issue: 8
Page: 647-665
Authors: Paolo Baldo, Sara Cecco, Elisa Giacomin, Renzo Lazzarini, Barbara Ros and Stefano Marastoni

The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma

Journal: Current Medicinal Chemistry
Volume: 17, Issue: 29
Page: 3327-3336
Authors: S. Pasquali and S. Mocellin

Therapy for Non-Clear Cell Histologies in Renal Cancer

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 169-180
Authors: Rhonda L. Bitting, John Madden and Andrew J. Armstrong

Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12, Issue: 2
Page: 129-136
Authors: Fred Saad and Peter Mulders

Stable Disease in Renal Cell Carcinoma After Using Signal Transduction Inhibitors

Journal: Reviews on Recent Clinical Trials
Volume: 5, Issue: 2
Page: 117-122
Authors: Saby George, Shetal N. Shah and Ronald M. Bukowski

Targeted Agents for the Treatment of Advanced Renal Cell Carcinoma

Journal: Current Drug Targets
Volume: 6, Issue: 7
Page: 835-846
Authors: M. Staehler, K. Rohrmann, N. Haseke, C. G. Stief and M. Siebels

Tumor Cell-Based Vaccination in Renal Cell Carcinoma: Rationale,Approaches, and Recent Clinical Development

Journal: Current Drug Targets
Volume: 3, Issue: 5
Page: 401-408
Authors: Johannes Volk, Saadettin Sel, Arnold Ganser and Patrick Schoffski

Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma

Journal: Current Cancer Drug Targets
Volume: 8, Issue: 8
Page: 676-682
Authors: Daniel Y.C. Heng and Ronald M. Bukowski

Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

Journal: Current Cancer Drug Targets
Volume: 10, Issue: 7
Page: 772-781
Authors: C. D'Alterio, C. Consales, M. Polimeno, R. Franco, L. Cindolo, L. Portella, M. Cioffi, R. Calemma, L. Marra, L. Claudio, S. Perdona, S. Pignata, G. Facchini, G. Carteni, N. Longo, L. Pucci, A. Ottaiano, S. Costantini, G. Castello and S. Scala

Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 181-188
Authors: Priti Patel and Sandy Srinivas

Alpha-Interferon and Its Effects on Signalling Pathways Within Cells

Journal: Current Protein & Peptide Science
Volume: 5, Issue: 6
Page: 475-485
Authors: Michele Caraglia, Giovanni Vitale, Monica Marra, Alfredo Budillon, Pierosandro Tagliaferri and Alberto Abbruzzese

Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways

Journal: Current Topics in Medicinal Chemistry
Volume: 11, Issue: 12
Page: 1571-1590
Authors: Haizhen Zhong and J. Phillip Bowen

The Eker Rat: Establishing a Genetic Paradigm Linking Renal Cell Carcinoma and Uterine Leiomyoma

Journal: Current Molecular Medicine
Volume: 4, Issue: 8
Page: 813-824
Authors: J. D. Cook and C. L. Walker

Therapeutic Enhancement of IL-2 Through Molecular Design

Journal: Current Pharmaceutical Design
Volume: 8, Issue: 24
Page: 2171-2183
Authors: Delanie J. Cassell, Shurjeel Choudhri, Rachel Humphrey, Robert E. Martell, Theresa Reynolds and Armen B. Shanafelt

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Journal: Current Cancer Drug Targets
Volume: 9, Issue: 2
Page: 237-249
Authors: Todd M. Morgan, Theodore D. Koreckij and Eva Corey

Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain

Journal: Current Pharmaceutical Design
Volume: 16, Issue: 29
Page: 3255-3263
Authors: M. Zatovicova, L. Jelenska, A. Hulikova, L. Csaderova, Z. Ditte, P. Ditte, T. Goliasova, J. Pastorek and S. Pastorekova

Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 189-198
Authors: Marc R. Matrana, Bradley Atkinson, Eric Jonasch and Nizar M. Tannir

New Anti-Angiogenic Targeted Therapy in Advanced Renal Cell Carcinoma (RCC):Current Status and Future Prospects

Journal: Reviews on Recent Clinical Trials
Volume: 3, Issue: 2
Page: 97-103
Authors: Alessandro Sciarra, Vincenzo Gentile, Stefano Salciccia, Andrea Alfarone and Franco Di Silverio

Interleukin-2 Immunotherapy and AIDS-Related Cytomegalovirus Retinitis

Journal: Current HIV Research
Volume: 2, Issue: 4
Page: 333-342
Authors: Richard D. Dix and Scott W. Cousins

Recent Advances in the Research and Development of RAF Kinase Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 6, Issue: 11
Page: 1071-1089
Authors: Roger A. Smith, Jacques Dumas, Lila Adnane and Scott M. Wilhelm

The Genetic Basis of Kidney Cancer: Why is Tuberous Sclerosis Complex Often Overlooked?

Journal: Current Molecular Medicine
Volume: 4, Issue: 8
Page: 825-831
Authors: Elizabeth Petri Henske

Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 11
Page: 1058-1077
Authors: Snezana K. Bjelogrlic, Sinisa Radulovic and Nada Babovic

The Applicability of mTOR Inhibition in Solid Tumors

Journal: Current Cancer Drug Targets
Volume: 9, Issue: 3
Page: 439-450
Authors: I.R. H.M. Konings, J. Verweij, E. A.C. Wiemer and S. Sleijfer

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8, Issue: 1
Page: 11-25
Authors: Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

Looking Beyond Inhibition of VEGF/mTOR: Emerging Targets for Renal Cell Carcinoma Drug Development

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 199-206
Authors: Neal Rasmussen and W. Kimryn Rathmell

Novel Therapeutic Options in Metastatic Renal Cancer – Review and Post ASCO 2007 Update

Journal: Reviews on Recent Clinical Trials
Volume: 3, Issue: 3
Page: 212-216
Authors: Stephan Kruck, Markus A. Kuczyk, Georgios Gakis, Mario W. Kramer, Arnulf Stenzl and Axel S. Merseburger

VEGF and HIF in Renal Cell Carcinogenesis

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 1, Issue: 1
Page: 60-67
Authors: Minardi Daniele, Lucarini Guendalina, d' Anzeo Gianluca, Conti Alessandro, Di Primio Roberto, Montironi Rodolfo and Muzzonigro Giovanni

Sorafenib (BAY 43-9006): Review of Clinical Development

Journal: Current Clinical Pharmacology
Volume: 1, Issue: 3
Page: 223-228
Authors: Raymond Ng and Eric X. Chen

Von Hippel-Lindau Disease

Journal: Current Molecular Medicine
Volume: 4, Issue: 8
Page: 833-842
Authors: Eamonn R. Maher

Targeted Therapies in the Treatment of Renal Cell Carcinoma

Journal: Current Medicinal Chemistry
Volume: 15, Issue: 12
Page: 1166-1174
Authors: Carmel Pezaro and Ian D. Davis

Interleukin 2 in Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 17, Issue: 29
Page: 3297-3302
Authors: G. K. Antony and A. Z. Dudek

Targeted-Therapy in Advanced Renal Cell Carcinoma

Journal: Current Medicinal Chemistry
Volume: 18, Issue: 11
Page: 1651-1657
Authors: M.T. Pirrotta, P. Bernardeschi and G. Fiorentini

Immunotherapy and Targeted Therapy Combinations in Renal Cancer

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 207-213
Authors: David F. McDermott

A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9, Issue: 1
Page: 76-83
Authors: M. Matsuyama and R. Yoshimura

A Brief Evaluation of Tumor Imaging in Mice with 99mTc-glucarate Including a Comparison with 18F-FDG

Journal: Current Radiopharmaceuticals
Volume: 4, Issue: 1
Page: 5-9
Authors: Donald Hnatowich, Xinrong Liu, Guozheng Liu, Yuzhen Wang, Yuxia Liu, Dengfeng Cheng and Mary Rusckowski

Renal Cell Cancer and Positron Emission Tomography- an Evolving Diagnostic and Therapeutic Relationship

Journal: Current Medical Imaging
Volume: 3, Issue: 1
Page: 17-26
Authors: Nathan Lawrentschuk, Damien M. Bolton, Ian D. Davis and Andrew M. Scott

Familial Non-Syndromic Clear Cell Renal Cell Carcinoma

Journal: Current Molecular Medicine
Volume: 4, Issue: 8
Page: 843-848
Authors: Emma R. Woodward

Wnt Signaling in Renal Cancer

Journal: Current Drug Targets
Volume: 9, Issue: 7
Page: 591-600
Authors: Hector Guillen-Ahlers

Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10, Issue: 3
Page: 225-235
Authors: J. Ansari, J. Glaholm, R. McMenemin, N.D. James and S.A. Hussain

Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 144-150
Authors: Michel Choueiri, Nizar Tannir and Eric Jonasch

Therapeutic Rationale for mTOR Inhibition in Advanced Renal Cell Carcinoma

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 214-221
Authors: Holleh D. Husseinzadeh and Jorge A. Garcia

Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 4, Issue: 2
Page: 75-78
Authors: Akira Miyajima, Eiji Kikuchi, Takeo Kosaka and Mototsugu Oya

Tyrosine Kinase Inhibitors, Pancreatic Hyperenzymemia and Acute Pancreatitis: A Review

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 5, Issue: 2
Page: 165-168
Authors: Raffaele Pezzilli, Dario Fabbri, Andrea Imbrogno and Roberto Corinaldesi